Aquestive Therapeutics (AQST) Inventory (2017 - 2026)

Aquestive Therapeutics' Inventory history runs 10 years deep, the most recent figure standing at $8.1 million for Q1 2026.

• In Q1 2026, Inventory rose 12.06% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $8.1 million (up 12.06% YoY), while the FY2025 annual figure was $6.2 million, up 2.07% from the prior year.
• Inventory was $8.1 million for Q1 2026 at Aquestive Therapeutics, up from $6.2 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $8.1 million in Q2 2025 to a low of $4.6 million in Q1 2022.
• Historically, Inventory has averaged $6.7 million across 5 years, with a median of $7.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Inventory jumped 134.89% in 2022, then declined 10.71% in 2024.
• A 5-year view of Inventory shows it stood at $5.8 million in 2022, then increased by 17.11% to $6.8 million in 2023, then dropped by 10.71% to $6.0 million in 2024, then gained by 2.07% to $6.2 million in 2025, then soared by 30.75% to $8.1 million in 2026.
• The last three Inventory figures came in at $8.1 million (Q1 2026), $6.2 million (Q4 2025), and $7.9 million (Q3 2025), per Business Quant data.